You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 215371


✉ Email this page to a colleague

« Back to Dashboard


NDA 215371 describes MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4, which is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from one supplier. Additional details are available on the MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 profile page.

The generic ingredient in MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 is magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are one hundred and forty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.
Suppliers and Packaging for NDA: 215371
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 215371 ANDA Fresenius Kabi USA, LLC 65219-389 65219-389-05 20 BAG in 1 CASE (65219-389-05) / 500 mL in 1 BAG (65219-389-00)
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 215371 ANDA Fresenius Kabi USA, LLC 65219-389 65219-389-10 10 BAG in 1 CASE (65219-389-10) / 1000 mL in 1 BAG (65219-389-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML
Approval Date:Jun 8, 2022TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.